• Tue, December 7, 2021
• Wed, December 8, 2021
Jeffrey Hung Maintained (ACAD) at Hold with Increased Target to $24 on, Dec 7th, 2021
Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $21 to $24 on, Dec 7th, 2021.
Jeffrey has made no other calls on ACAD in the last 4 months.
There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Jeffrey's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jeffrey
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021
Like: 👍
